(Q46463587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Colette B Raymond

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Health-System Pharmacy

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1419-1429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Calcific uremic arteriolopathy: advances in pathogenesis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Calciphylaxis--a topical overview

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Acute hypercalcemia of the heart ("bony heart")

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Acute respiratory failure due to "pulmonary calciphylaxis" in a maintenance haemodialysis patient

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Calciphylaxis: natural history, risk factor analysis, and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Is calciphylaxis best treated surgically or medically?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

The evolving pattern of calciphylaxis: therapeutic considerations

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Therapy for calciphylaxis: an outcome analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Long-term outcomes in patients with calciphylaxis from hyperparathyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Low-dose tissue plasminogen activator for calciphylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Painful ulcers in calciphylaxis - combined treatment with maggot therapy and oral pentoxyfillin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Cutaneous necrosis from calcific uremic arteriolopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Successful treatment of calciphylaxis with intravenous sodium thiosulfate

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Intraperitoneal Sodium Thiosulfate for the Treatment of Calciphylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Necrotizing mastitis caused by calciphylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Bone scintigraphy of calciphylaxis: a syndrome of vascular calcification and skin necrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Is there a role for bisphosphonates in chronic kidney disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Cinacalcet as an adjunct in the successful treatment of calciphylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Successful treatment of calciphylaxis with cinacalcet-an alternative to parathyroidectomy?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Cinacalcet as first-line treatment for calciphylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Case records of the Massachusetts General Hospital. Case 7-2007. A 59-year-old woman with diabetic renal disease and nonhealing skin ulcers

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

Images in clinical medicine. Calciphylaxis with arterial calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070546

31 March 2020

Identifiers

DOI

10.2146/AJHP070546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18653812%20AND%20SRC:MED&resulttype=core&format=json

release_ape4usfktfavfiapgcwuppycdq

11 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ape4usfktfavfiapgcwuppycdq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference